These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 1371513)

  • 1. Vasoactive intestinal peptide and forskolin regulate proliferation of the HT29 human colon adenocarcinoma cell line.
    Gamet L; Murat JC; Remaury A; Remesy C; Valet P; Paris H; Denis-Pouxviel C
    J Cell Physiol; 1992 Mar; 150(3):501-9. PubMed ID: 1371513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vasoactive intestinal polypeptide inhibits c-myc expression and growth of human gastric carcinoma cells.
    Kim SW; Beauchamp RD; Townsend CM; Thompson JC
    Surgery; 1991 Aug; 110(2):270-5; discussion 276. PubMed ID: 1713357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of DNA synthesis in dog thyrocytes in primary culture: synergistic effects of thyrotropin and cyclic AMP with epidermal growth factor and insulin.
    Roger PP; Servais P; Dumont JE
    J Cell Physiol; 1987 Jan; 130(1):58-67. PubMed ID: 3027108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dual effects of glucagon and cyclic AMP on DNA synthesis in cultured rat hepatocytes: stimulatory regulation in early G1 and inhibition shortly before the S phase entry.
    Thoresen GH; Sand TE; Refsnes M; Dajani OF; Guren TK; Gladhaug IP; Killi A; Christoffersen T
    J Cell Physiol; 1990 Sep; 144(3):523-30. PubMed ID: 2167904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclic AMP-dependent protein kinase in Molt 4b lymphoblasts: identification by photoaffinity labeling and activation in intact cells by vasoactive intestinal polypeptide (VIP) and peptide histidine isoleucine (PHI).
    O'Dorisio MS; Wood CL; Wenger GD; Vassalo LM
    J Immunol; 1985 Jun; 134(6):4078-86. PubMed ID: 2985703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of vasoactive intestinal peptide on adenosine 3',5'-monophosphate, ornithine decarboxylase, and cell growth in a human colon cell line.
    Yu D; Seitz PK; Selvanayagam P; Rajaraman S; Townsend CM; Cooper CW
    Endocrinology; 1992 Sep; 131(3):1188-94. PubMed ID: 1324153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of human B cell activation by diterpine forskolin: interference with B cell growth factor-induced G1 to S transition of the B cell cycle.
    Muraguchi A; Miyazaki K; Kehrl JH; Fauci AS
    J Immunol; 1984 Sep; 133(3):1283-7. PubMed ID: 6086754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. cAMP-mediated growth inhibition of a B-lymphoid precursor cell line Reh is associated with an early transient delay in G2/M, followed by an accumulation of cells in G1.
    Blomhoff HK; Blomhoff R; Stokke T; deLange Davies C; Brevik K; Smeland EB; Funderud S; Godal T
    J Cell Physiol; 1988 Dec; 137(3):583-7. PubMed ID: 2848044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vasoactive intestinal peptide receptor regulation and reversible desensitization in human colonic carcinoma cells in culture.
    Boissard C; Marie JC; Hejblum G; Gespach C; Rosselin G
    Cancer Res; 1986 Sep; 46(9):4406-13. PubMed ID: 3015387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vasoactive intestinal peptide (VIP) stimulates in vitro growth of VIP-1 receptor-bearing human pancreatic adenocarcinoma-derived cells.
    Jiang S; Kopras E; McMichael M; Bell RH; Ulrich CD
    Cancer Res; 1997 Apr; 57(8):1475-80. PubMed ID: 9108448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of prostate-specific antigen (PSA) gene expression and release in LNCaP prostate cancer by antagonists of growth hormone-releasing hormone and vasoactive intestinal peptide.
    Rekasi Z; Schally AV; Plonowski A; Czompoly T; Csernus B; Varga JL
    Prostate; 2001 Aug; 48(3):188-99. PubMed ID: 11494334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of ornithine decarboxylase in the control of proliferation of the HT29 human colon cancer cell line. Effect of vasoactive intestinal peptide on enzyme activity.
    Gamet L; Cazenave Y; Trocheris V; Denis-Pouxviel C; Murat JC
    Int J Cancer; 1991 Feb; 47(4):633-8. PubMed ID: 1847359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vasoactive intestinal peptide control of cyclic adenosine 3':5'-monophosphate levels in seven human colorectal adenocarcinoma cell lines in culture.
    Laburthe M; Rousset M; Chevalier G; Boissard C; Dupont C; Zweibaum A; Rosselin G
    Cancer Res; 1980 Jul; 40(7):2529-33. PubMed ID: 6248206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mode of estrogen action on cell proliferation in CAMA-1 cells: II. Sensitivity of G1 phase population.
    Leung BS; Potter AH
    J Cell Biochem; 1987 Jul; 34(3):213-25. PubMed ID: 3611201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Inhibition of cell proliferation and C-myc cancer protein expression in human colon adenocarcinoma cell line HT29 with VIP-131I-ASON].
    Ou X; Tan T; Li Y
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2006 Oct; 23(5):1096-100. PubMed ID: 17121362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of melatonin on chicken lymphocytes in vitro: involvement of membrane receptors.
    Markowska M; Mrozkowiak A; Skwarlo-Sonta K
    Neuro Endocrinol Lett; 2002 Apr; 23 Suppl 1():67-72. PubMed ID: 12019355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. cAMP-mediated signals as determinants for apoptosis in primary granulosa cells.
    Aharoni D; Dantes A; Oren M; Amsterdam A
    Exp Cell Res; 1995 May; 218(1):271-82. PubMed ID: 7537693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antagonistic growth regulation of cell lines derived from human lung adenocarcinomas of Clara cell and aveolar type II cell lineage: Implications for chemoprevention.
    Adissu HA; Schuller HM
    Int J Oncol; 2004 Jun; 24(6):1467-72. PubMed ID: 15138589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resumption of cell cycle in BALB/c-3T3 fibroblasts arrested by polyamine depletion: relation with "competence" gene expression.
    Charollais RH; Mester J
    J Cell Physiol; 1988 Dec; 137(3):559-64. PubMed ID: 3142887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification, characterization, and biological activity of somatostatin receptors in human neuroblastoma cell lines.
    Maggi M; Baldi E; Finetti G; Franceschelli F; Brocchi A; Lanzillotti R; Serio M; Camboni MG; Thiele CJ
    Cancer Res; 1994 Jan; 54(1):124-33. PubMed ID: 8261433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.